Company profile: TriPharm
1.1 - Company Overview
Company description
- Provider of pharmaceuticals as a privately held pharmaceuticals company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to TriPharm
IQuum
HQ: United States
Website
- Description: Provider of molecular diagnostics and biological sample technology, developing an early-stage platform to improve extraction of information from biological samples and deliver recent advances in genomics and biotechnology to healthcare and daily life; founded in 1998 in the Boston metropolitan area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IQuum company profile →
MaxThera
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development of new treatments for bacterial infections, especially those caused by drug-resistant bacteria.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MaxThera company profile →
BioMed Diagnostics
HQ: United States
Website
- Description: Provider of highly selective pre-plated prepared media culture devices that combine inoculation, culture, transport, and result analysis to reduce lab labor and costs. Solutions span clinical, veterinary point-of-care, and industrial microbiology for environmental monitoring and compliance, including InPouch, InTray, and PCR-compatible Transit Tube.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMed Diagnostics company profile →
Epixis
HQ: France
Website
- Description: Provider of advanced immuno-therapy development based on recombinant virus-like particles against hepatitis C, based in Paris, France.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epixis company profile →
Siga Technologies
HQ: United States
Website
- Description: Provider of antiviral therapeutics for lethal pathogens, specializing in smallpox. Products include TPOXX (Tecovirimat-SIGA), approved for treatment of smallpox and, in various regions, monkeypox, cowpox, and vaccinia complications, and TPOXX Injection, an intravenous formulation for smallpox patients unable to swallow oral capsules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siga Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for TriPharm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to TriPharm
2.2 - Growth funds investing in similar companies to TriPharm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for TriPharm
4.2 - Public trading comparable groups for TriPharm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →